EosGene Tx
EosGene Therapeutics
Providing patients
with life-changing cures
What We Do
Our approach employs the revolutionary CRISPR editing tool to precisely target the disease-associated gene, paving the way for therapeutic breakthroughs.
To ensure both effectiveness and safety of the therapy, we have developed an innovative liposome delivery technology that achieves the spatial-temporal release of CRISPR agents to the affected cells.
Our objective is to halt or reverse the progression of diabetic retinopathy by correcting underpinning genetic dysfunctions at their source.
Who We Are
EosGene brings together world-class scientists with expertise in bio- and chemical technologies and highly experienced business leaders,
Our team of medical advisors guides our preclinical and clinical studies.
With our ground-breaking liposome delivery technology, we are at the forefront of the emerging wave of genetic cures.
These will transform the available treatment options for currently untreatable genetic conditions.
